Study directory

Mental health studies with practical context.

Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.

Back to overview
1200studies shown
Showing 73-84 of 1,200
Drug study icon
RecruitingNCT06951711

KarXT for manic episodes in bipolarity type I

This study is recruiting in the United States, in Croatia, in India, .... It is testing KarXT for manic episodes in bipolarity type I.

In United States
BipolarityDrugA study involving a medication or substance.From 18 Years to 65 Years
Countries
United States, Croatia, India, ...
Sponsor
Bristol-Myers Squibb
Condition
Bipolarity
Drug study icon
RecruitingNCT07288567

KarXT for schizophrenia

This study is recruiting in the United States, in Argentina, in Colombia, .... It is testing KarXT for schizophrenia.

In United States
SchizophreniaOtherFrom 13 Years to 17 Years
Countries
United States, Argentina, Colombia, ...
Sponsor
Bristol-Myers Squibb
Condition
Schizophrenia
Other study type icon
RecruitingNCT07065240

SPT-300 (GlyphAllo) for depression

This study is recruiting in the United States, in Bulgaria, in Czechia, .... It is testing SPT-300 (GlyphAllo) for depression.

In United States
DepressionOtherFrom 18 Years to 65 Years
Countries
United States, Bulgaria, Czechia, ...
Sponsor
Seaport Therapeutics
Condition
Depression
Drug study icon
RecruitingNCT07424404

KarXT and KarX-EC for schizophrenia

This study is recruiting in the United States, in France, in Canada, .... It is testing KarXT and KarX-EC for schizophrenia.

In United States
SchizophreniaOtherFrom 5 Years to 17 Years
Countries
United States, France, Canada, ...
Sponsor
Karuna Therapeutics, Inc., a Bristol Myers Squibb company
Condition
Schizophrenia
Other study type icon
RecruitingNCT07196501

Maintenance Effect of NBI-1065845 for depression

This study is recruiting in the United States, in Australia, in Canada, .... It is testing Maintenance Effect of NBI-1065845 for depression.

In United States
DepressionOtherOver 18 Years
Countries
United States, Australia, Canada, ...
Sponsor
Neurocrine Biosciences
Condition
Depression
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.